Increased levels of soluble complement receptor 1 in serum of patients with liver diseases

Hepatology

Volumn 24, Issue 1, 1996, Pages 118-122

  Sadallah, Salima ^a   Giostra, Emiliano ^b   Mentha, Gilles ^b   Schifferli, Jürg A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR;

AMANITA PHALLOIDES; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0029938577     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008707249     Document Type: Article

References (19)

1. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leucocyte, B lymphocyte, and monocyte. J Exp Med 1980;152:20-30.
2. Fearon DT, Ahearn JM. Complement receptor type 1 (C3b/C4b receptor; CD 35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD 21). In: Lambris JD, ed. Current topics in microbiology and immunology (the third component of complement). Ed 153. Berlin: Springer Verlag, 1989;153:83-98.
3. Wrigh SD, Silverstein SC. Tumor promoting phorbol esters stimulate C3b and C3bi receptor-mediated phagocytosis in cultured human monocytes. J Exp Med 1982;156:1149-1164.
4. Medof ME, Iida K, Mold C, Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 1982;156:1739-1754.
5. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, et al. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990;249:146-151.
6. Yoon SH, Fearon DT. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol 1985;134:3332-3337.
7. Pascual M, Duchosal MA, Steiger G, Giostra E, Pechère A, Paccaud JP, Danielsson C, et al. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leucocytes. J Immunol 1993; 151:1702-1711.
8. Danielsson C, Pascual M, French L, Steiger G, Schifferli JA. Soluble CR1 (CD35) is released from leucocytes by surface cleavage. Eur J Immunol 1994;24:2725-2731.
9. Hinglais N, Kazatchkine MD, Mandet C, Appay MD, Bariety J. Human liver Kupffer cells express CR1, CR3 and CR4 complement receptor antigens. Lab Invest 1989;61:509-514.
10. 9a. Thompson RA, Carter R, Stokes RP, Geddes AM, Goodall JAD. Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol 1973;14:335-346.
11. Pascual M, Steiger G, Sadallah S, Paccaud JP, Carpentier JL, James RJ, Schifferli JA, et al. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med 1994;179:889-899.
12. Merkel C, Sacerdoti D, Finucci GF, Zuin R, Bazzerla G, Bolognesi M, Gatta A, et al. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. Br J Clin Pharm 1986;21:713-719.
13. Faulstich H. New aspects of Amanita poisoning. Klin Wochenschr 1979; 57:1143-1152.
14. Thompson RA, Carter R, Stokes RP, Geddes AM, Goodall JA. Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol 1973;14:335-346.
15. Würzner R, Josey VC, Lachmann PJ. Complement component C7 assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7. J Immunol 1994;152: 4624-4629.
16. Thomson AW, Satoh S, Nüssler AK, Tamura K, Woo J, Gavaler J, Van Thiel DH. Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol 1994;95:83-90.
17. Pascual M, Lutz HU, Steiger G, Stammler P, Schifferli JA. Release of vesicles enriched in complement receptor 1 from human erythrocytes. J Immunol 1993;151:397-404.
18. Hobart MJ, Lachmann PJ, Calne RY. C6: Synthesis by the liver in vivo. J Exp Med 1977;146:629-630.
19. 1-antitrypsin, C8 and factor B. Clin Immunol Immunopathol 1980;16:84-89.